MetLife Investment Management’s Marqeta MQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$782K Sell
47,898
-1,482
-3% -$25K ﹤0.01% 1521
2025
Q4
$938K Sell
49,380
-6,209
-11% -$119K ﹤0.01% 1468
2025
Q3
$1.17M Sell
55,589
-2,098
-4% -$49.7K 0.01% 1349
2025
Q2
$1.35M Sell
57,687
-11,872
-17% -$225K 0.01% 1168
2025
Q1
$1.15M Sell
69,559
-307
-0.4% -$4.84K 0.01% 1290
2024
Q4
$1.06M Buy
69,866
+2,342
+3% +$41.1K 0.01% 1379
2024
Q3
$1.33M Hold
67,524
0.01% 1231
2024
Q2
$1.48M Buy
67,524
+7,716
+13% +$170K 0.01% 1135
2024
Q1
$1.43M Sell
59,808
-5,079
-8% -$126K 0.01% 1106
2023
Q4
$1.81M Hold
64,887
0.01% 983
2023
Q3
$1.55M Hold
64,887
0.01% 1016
2023
Q2
$1.26M Buy
64,887
+7,463
+13% +$135K 0.01% 1140
2023
Q1
$1.05M Hold
57,424
0.01% 1202
2022
Q4
$1.4M Sell
57,424
-1,696
-3% -$46.3K 0.01% 1042
2022
Q3
$1.68M Buy
59,120
+2,366
+4% +$78.8K 0.01% 951
2022
Q2
$1.84M Buy
+56,754
New +$2.23M 0.01% 933

Other funds holding MQ

MetLife Investment Management's MQ Position: Q1 2026 in Review

MetLife Investment Management reduced its Marqeta (MQ) stake by 3% in Q1 2026, selling an estimated $25K and leaving 47,898 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.

MetLife Investment Management first reported a position in MQ in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.84M in Q2 2022. 253 funds tracked by Wall St. Rank hold MQ as of Q1 2026.

  • MetLife Investment Management held 47,898 shares of Marqeta worth $782K as of Q1 2026.
  • MetLife Investment Management sold 1,482 Marqeta shares in Q1 2026, an estimated $25K.
  • Marqeta made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1521 holding.
  • MetLife Investment Management first reported a position in Marqeta in Q2 2022 and has held it in 16 quarters since.
  • MetLife Investment Management's Marqeta position peaked at $1.84M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held Marqeta as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.